Amgen Interest Income from 2010 to 2026

AMGN Stock

USD 366.20 0.38 0.10%

Amgen Interest Income yearly trend continues to be very stable with very little volatility. Interest Income is likely to drop to about 218.9 M. Interest Income is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. View All Fundamentals

Interest Income

First Reported

2010-12-31

Previous Quarter

230.4 M

Current Value

218.9 M

Quarterly Volatility

209.6 M

Credit Downgrade

Yuan Drop

Covid

Interest Hikes

Check Amgen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amgen's main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.6 B, Interest Expense of 2.9 B or Selling General Administrative of 2.7 B, as well as many indicators such as Price To Sales Ratio of 8.8, Dividend Yield of 0.0194 or PTB Ratio of 21.36. Amgen financial statements analysis is a perfect complement when working with Amgen Valuation or Volatility modules.

Build AI portfolio with Amgen Stock

Check out the analysis of Amgen Correlation against competitors.

Evaluating Amgen's Interest Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Amgen Inc's fundamental strength.

Latest Amgen's Interest Income Growth Pattern

Below is the plot of the Interest Income of Amgen Inc over the last few years. It is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. Amgen's Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amgen's overall financial position and show how it may be relating to other accounts over time.

Interest Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Interest Income

Timeline

Amgen Interest Income Regression Statistics

	Arithmetic Mean	450,898,824
	Geometric Mean	407,233,116
	Coefficient Of Variation	46.48
	Mean Deviation	167,883,737
	Median	492,000,000
	Standard Deviation	209,597,960
	Sample Variance	43931.3T
	Range	709.1M
	R-Value	(0.54)
	Mean Square Error	33074.6T
	R-Squared	0.29
	Significance	0.02
	Slope	(22,512,647)
	Total Sum of Squares	702900.9T

Amgen Interest Income History

	2026	218.9 M
	2025	230.4 M
	2020	256 M
	2019	753 M
	2018	674 M
	2017	928 M
	2016	629 M

Other Fundumenentals of Amgen Inc

Net Interest Income

Amgen Interest Income component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Accounts Payable	Short Term Investments	Capital Stock	Common Stock	Long Term Debt	Property Plant Equipment	Good Will	Intangible Assets	Net Tangible Assets	Long Term Debt Total	Deferred Long Term Liab	Current Deferred Revenue	Long Term Investments	Short Long Term Debt	Net Invested Capital	Net Working Capital
Total Assets		0.19	0.95	-0.47	0.75	0.92	0.54	0.55	0.46	0.32	0.82	0.29	0.89	0.8	0.86	0.42	-0.54	0.85	0.31	0.38	0.58	0.4	0.27	-0.43
Total Stockholder Equity	0.19		-0.07	0.7	-0.41	-0.22	0.76	0.11	-0.18	0.86	0.23	0.33	-0.19	0.24	-0.14	-0.56	0.64	-0.05	0.6	-0.18	-0.2	0.07	0.26	0.71
Net Debt	0.95	-0.07		-0.61	0.86	0.97	0.32	0.55	0.52	0.12	0.69	0.14	0.96	0.69	0.91	0.62	-0.67	0.83	0.16	0.44	0.58	0.37	0.33	-0.56
Retained Earnings	-0.47	0.7	-0.61		-0.82	-0.75	0.28	-0.21	-0.38	0.61	-0.5	-0.1	-0.68	-0.48	-0.64	-0.62	0.96	-0.63	0.36	-0.32	-0.5	-0.14	0.28	0.95
Net Receivables	0.75	-0.41	0.86	-0.82		0.92	-0.07	0.46	0.74	-0.27	0.56	-0.15	0.95	0.6	0.77	0.6	-0.83	0.74	-0.08	0.66	0.61	0.26	0.1	-0.82
Total Liab	0.92	-0.22	0.97	-0.75	0.92		0.22	0.51	0.54	-0.04	0.71	0.14	0.97	0.69	0.91	0.64	-0.79	0.86	0.07	0.46	0.66	0.37	0.16	-0.72
Total Current Assets	0.54	0.76	0.32	0.28	-0.07	0.22		0.28	-0.17	0.88	0.58	0.55	0.15	0.51	0.33	-0.24	0.28	0.42	0.52	-0.11	0.24	0.39	0.3	0.38
Short Term Debt	0.55	0.11	0.55	-0.21	0.46	0.51	0.28		0.56	0.3	0.37	-0.17	0.52	0.38	0.44	0.11	-0.23	0.34	0.12	0.52	0.3	0.8	0.25	-0.25
Accounts Payable	0.46	-0.18	0.52	-0.38	0.74	0.54	-0.17	0.56		-0.09	0.22	-0.66	0.69	0.34	0.35	0.19	-0.4	0.35	-0.01	0.94	0.38	0.19	0.27	-0.46
Short Term Investments	0.32	0.86	0.12	0.61	-0.27	-0.04	0.88	0.3	-0.09		0.22	0.23	-0.03	0.19	0.02	-0.44	0.59	0.08	0.56	-0.07	0.05	0.32	0.43	0.64
Capital Stock	0.82	0.23	0.69	-0.5	0.56	0.71	0.58	0.37	0.22	0.22		0.56	0.63	0.95	0.75	0.21	-0.52	0.86	0.22	0.24	0.47	0.32	-0.02	-0.41
Common Stock	0.29	0.33	0.14	-0.1	-0.15	0.14	0.55	-0.17	-0.66	0.23	0.56		-0.06	0.43	0.26	-0.01	-0.1	0.34	0.19	-0.66	0.05	0.06	-0.32	0.04
Long Term Debt	0.89	-0.19	0.96	-0.68	0.95	0.97	0.15	0.52	0.69	-0.03	0.63	-0.06		0.67	0.85	0.6	-0.72	0.79	0.07	0.61	0.58	0.3	0.31	-0.65
Property Plant Equipment	0.8	0.24	0.69	-0.48	0.6	0.69	0.51	0.38	0.34	0.19	0.95	0.43	0.67		0.68	0.12	-0.46	0.78	0.12	0.34	0.33	0.2	0.1	-0.34
Good Will	0.86	-0.14	0.91	-0.64	0.77	0.91	0.33	0.44	0.35	0.02	0.75	0.26	0.85	0.68		0.74	-0.72	0.92	0.16	0.38	0.59	0.43	0.27	-0.6
Intangible Assets	0.42	-0.56	0.62	-0.62	0.6	0.64	-0.24	0.11	0.19	-0.44	0.21	-0.01	0.6	0.12	0.74		-0.74	0.52	-0.07	0.21	0.41	0.19	0.2	-0.66
Net Tangible Assets	-0.54	0.64	-0.67	0.96	-0.83	-0.79	0.28	-0.23	-0.4	0.59	-0.52	-0.1	-0.72	-0.46	-0.72	-0.74		-0.69	0.22	-0.34	-0.55	-0.16	0.27	0.97
Long Term Debt Total	0.85	-0.05	0.83	-0.63	0.74	0.86	0.42	0.34	0.35	0.08	0.86	0.34	0.79	0.78	0.92	0.52	-0.69		0.19	0.39	0.68	0.31	0.08	-0.58
Deferred Long Term Liab	0.31	0.6	0.16	0.36	-0.08	0.07	0.52	0.12	-0.01	0.56	0.22	0.19	0.07	0.12	0.16	-0.07	0.22	0.19		-0.03	0.03	0.25	0.1	0.25
Current Deferred Revenue	0.38	-0.18	0.44	-0.32	0.66	0.46	-0.11	0.52	0.94	-0.07	0.24	-0.66	0.61	0.34	0.38	0.21	-0.34	0.39	-0.03		0.36	0.22	0.37	-0.4
Long Term Investments	0.58	-0.2	0.58	-0.5	0.61	0.66	0.24	0.3	0.38	0.05	0.47	0.05	0.58	0.33	0.59	0.41	-0.55	0.68	0.03	0.36		0.36	-0.09	-0.59
Short Long Term Debt	0.4	0.07	0.37	-0.14	0.26	0.37	0.39	0.8	0.19	0.32	0.32	0.06	0.3	0.2	0.43	0.19	-0.16	0.31	0.25	0.22	0.36		0.15	-0.21
Net Invested Capital	0.27	0.26	0.33	0.28	0.1	0.16	0.3	0.25	0.27	0.43	-0.02	-0.32	0.31	0.1	0.27	0.2	0.27	0.08	0.1	0.37	-0.09	0.15		0.34
Net Working Capital	-0.43	0.71	-0.56	0.95	-0.82	-0.72	0.38	-0.25	-0.46	0.64	-0.41	0.04	-0.65	-0.34	-0.6	-0.66	0.97	-0.58	0.25	-0.4	-0.59	-0.21	0.34

Click cells to compare fundamentals

About Amgen Financial Statements

Amgen investors utilize fundamental indicators, such as Interest Income, to predict how Amgen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

	Last Reported	Projected for Next Year
Interest Income	230.4 M	218.9 M
Net Interest Income	-2.8 B	-2.7 B

Pair Trading with Amgen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amgen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will appreciate offsetting losses from the drop in the long position's value.

Moving against Amgen Stock

0.63	LYRA	Lyra Therapeutics	Pair Corr
0.59	ABP	Abpro Holdings	Pair Corr
0.57	EDIT	Editas Medicine Earnings Call This Week	Pair Corr
0.56	QSI	QuantumSi	Pair Corr
0.49	KURA	Kura Oncology	Pair Corr

The ability to find closely correlated positions to Amgen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amgen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amgen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amgen Inc to buy it.

The correlation of Amgen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amgen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amgen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Amgen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:

How To Invest In Amgen

Details

Is Amgen Stock a good investment?

Details

What is Amgen's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of Amgen Correlation against competitors.

You can also try the AI Portfolio Prophet module to use AI to generate optimal portfolios and find profitable investment opportunities.

Will Biotechnology sector continue expanding? Could Amgen diversify its offerings? Factors like these will boost the valuation of Amgen. If investors know Amgen will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Amgen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.

Quarterly Earnings Growth

1.116

Dividend Share

9.52

Earnings Share

14.22

Revenue Per Share

68.31

Quarterly Revenue Growth

0.086

Investors evaluate Amgen Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Amgen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Amgen's market price to deviate significantly from intrinsic value.

Understanding that Amgen's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Amgen represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Amgen's market price signifies the transaction level at which participants voluntarily complete trades.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Amgen Interest Income from 2010 to 2026

Latest Amgen's Interest Income Growth Pattern

Amgen Interest Income Regression Statistics

Amgen Interest Income History

Other Fundumenentals of Amgen Inc

Amgen Interest Income component correlations

About Amgen Financial Statements

Pair Trading with Amgen

Moving against Amgen Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY